Search

everythinglearnresearchcommunity

for

Search:↓

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

During late pregnancy in rats, hormonal changes increased certain GABAA receptors in specific brain cells.

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Propranolol affects heart rate and renin levels in minoxidil-treated patients.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Some dibenzo compounds might help treat cancer with fewer side effects.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Both drugs lower DHT levels, with GI198745 being more effective.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

The compound 4c showed strong potential as an anticancer agent.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.